The results suggest doctors should take their patients' preferences into consideration before recommending one test or the other, according to the researchers.
"The basic finding here is, when offered a choice, you not only get better screening participation, but also a significant proportion of people don't choose colonoscopy," said Dr. Linda Rabeneck, vice president of prevention and cancer control at Cancer Care Ontario, who was not involved in the research.
The new study, reported online today in the Archives of Internal Medicine by Dr. John Inadomi of the University of Washington School of Medicine in Seattle and colleagues, followed 997 people who were using the San Francisco public health system between 2007 and 2010.
Those people were randomly divided into three groups, all made up of men and women between 50 and 79 years old with an average risk of developing colorectal cancer. According to the American Cancer Society, a person's risk of developing the cancer over their lifetime is about one in 20.
For one group of participants, doctors only recommended colonoscopy. For another group, the doctors only recommended fecal occult blood testing. In the third group, doctors let patients choose between the two tests.
Overall, 58% of the study participants got the screening test their doctors had recommended or the one they picked themselves. But there were significant differences between the three groups.
Of the 337 people whose doctor advised colonoscopy, just 38% actually had one over the next 12 months. By comparison, among 344 people whose doctor recommended a fecal occult blood test, the compliance rate was 67%.
And among the 321 people who were given a choice, 69% had the test they had picked -- 122 opted for the stool test and 99 picked colonoscopy.
For those who picked the fecal occult blood test, the researchers did not consider their screenings complete if they tested positive but didn't get a follow-up colonoscopy to investigate further. Eight people who had the stool test got positive results, and three of those did not get a colonoscopy afterwards.
"There are a lot of factors that are associated with the choice of one test over another," Dr. Rabeneck told Reuters Health. "I think this drives it home in a very powerful way."
African Americans were the least likely to get screened at all, while Asians and Latinos were the most likely. Non-whites were also more likely to follow through with stool testing, while whites were more likely to actually get a colonoscopy.
Personal preferences will also play a role in a patient's choice, researchers say.
"Some will prefer a test that's easier and done at home. Some will prefer a colonoscopy and all that goes along with it," said Dr. Rabeneck.
According to the U.S. Preventive Services Task Force, people ages 50 to 75 should be screened by one of three methods: a colonoscopy every 10 years; annual stool testing; or a flexible sigmoidoscopy every five years in conjunction with stool testing every two to three years.
Dr. Inadomi's team originally expected that giving patients a choice would confuse or overwhelm them and potentially discourage them from making any decision or getting any test.
Based on their study's results, Dr. Inadomi told Reuters Health in an email he now thinks doctors should give patients choices.
"I would make sure that I took into account the patient's preferences. I would flat out describe these tests... I think this goes against what a lot of us are doing right now. We should be finding out what patients prefer and really pursuing that," Dr. Inadomi said.
"The study...demonstrates that not having enough choice may lead to inaction when the only choice is colonoscopy," wrote Dr. Theodore Levin, from Kaiser Permanente Medical Center in Walnut Creek, California, in a commentary published with the article.
Dr. Inadomi's team also notes that they did their best to reduce barriers to getting the tests, which included providing rides.
"We need to realize that if you provide access and an infrastructure even in a low income, low education environment you can get good compliance," he said.
By Andrew M. Seaman
Arch Int Med 2012.
Last Updated: 2012-04-09 19:15:10 -0400 (Reuters Health)
Copyright © 2012 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.